Article Text

Download PDFPDF
Back to the future

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Recent journal editorials have highlighted the challenges surrounding the complex, emotive and high-profile issue of funding cancer drugs.1,2 In particular, the UK coalition Government's proposal for a cancer drug fund, and the consequent undermining of the National Institute for Health and Clinical Excellence (NICE) in its evaluation of such drugs, have been called into question. There has also been the recent heated reaction to NICE's …

View Full Text